Indo US Bio-Tech Limited (INDOUS)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Sep 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 22.17 33.38 30.77 61.62 22.80
YOY Revenue Growth % - - - - 2.82%
Other Income 0.02 0.12 0.00 0.03 0.01
Total Income 22.19 33.50 30.77 61.64 22.80
Total Expenses + 13.66 29.63 25.95 53.27 19.64
Cost of Materials Consumed 11.14 30.83 8.84 28.34 15.60
Employee Benefit Expense 0.24 0.34 0.32 0.66 0.33
Other Expenses 2.28 4.05 2.86 5.45 2.34
Operating Profit 8.51 3.76 4.82 8.35 3.16
OPM % 38.4% 11.3% 15.7% 13.6% 13.9%
Profit Before Tax + 4.45 3.88 4.82 8.38 3.16
Tax Expense 0.09 0.19 0.12 0.22 0.17
Tax % 1.9% 5% 2.4% 2.7% 5.3%
Profit After Tax 4.36 3.68 4.70 8.15 3.00
EPS (Basic) 2.16 1.86 2.35 4.06 1.49

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025
Revenue from Operations 103.84
YOY Revenue Growth % -
Other Income 0.18
Total Income 104.02
Total Expenses + 87.49
Cost of Materials Consumed 70.96
Employee Benefit Expense 1.09
Other Expenses 11.15
Operating Profit 16.35
OPM % 15.7%
Profit Before Exceptional 16.53
Exceptional Items 0.00
Profit Before Tax + 16.53
Tax Expense 0.26
Tax % 1.6%
Profit After Tax 16.27
EPS (Basic) 8.12

Balance Sheet

Particulars Mar 2025
ASSETS
Non-Current Assets + 11.12
Property, Plant & Equipment 10.23
Capital Work in Progress 0.00
Non-Current Investments 0.00
Goodwill 0.00
Other Intangible Assets 0.00
Current Assets + 86.73
Inventories 70.69
Trade Receivables 15.00
Cash and Cash Equivalents 0.25
Current Investments 0.00
LIABILITIES & EQUITY
Total Equity 0.00
Equity Share Capital 20.05
Other Equity 58.47
Non-Current Liabilities 2.99
Current Liabilities 16.34
Total Liabilities 19.32

Cash Flow Statement

Particulars Mar 2025
Cash from Operating Activities -1.42
Cash from Investing Activities -0.79
Cash from Financing Activities -1.48
Net Increase/Decrease in Cash -3.69